To aid in selecting either TCZ or a TNF-i for the treatment of RA, we aimed to develop a scoring system that reflects the dominant cytokine and predicts the efficacy of medications by analyzing common clinical data. The gene discussed is TNF; the disease is rheumatoid arthritis.